Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Spohn

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
JAMA Network Open|February 22, 2023
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive RadiotherapyAlexander Rühle, Sebastian Marschner, Marlen Haderlein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ChemoradiationAlexander Rühle, Maria Weymann, Max Behrens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 22, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomySonja Adebahr, Alexander Althaus, Sophia Scharl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 19, 2022
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysisSimon K B Spohn, Andrea Farolfi, Sarah Schandeler, et al.
JAMA Network Open|May 23, 2023
Development and Validation of a Multi-institutional Nomogram of Outcomes for PSMA-PET-Based Salvage Radiotherapy for Recurrent Prostate CancerConstantinos Zamboglou, Jan C Peeken, Ali Janbain, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 17, 2023
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapySimon K B Spohn, Nina-Sophie Schmidt-Hegemann, Juri Ruf, et al.
JAMA Network Open|February 22, 2023
Evaluation of Concomitant Systemic Treatment in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive RadiotherapyAlexander Rühle, Sebastian Marschner, Marlen Haderlein, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2022
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After ProstatectomyConstantinos Zamboglou, Iosif Strouthos, Joerg Sahlmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 5, 2023
Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence- results of a retrospective studySophia Scharl, Constantinos Zamboglou, Iosif Strouthos, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive ChemoradiationAlexander Rühle, Maria Weymann, Max Behrens, et al.
International Journal of Radiation Oncology, Biology, Physics|January 3, 2023
Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International ConsensusSimon K B Spohn, Cédric Draulans, Amar U Kishan, et al.
Pageof 8